Amgen Lp(a) - OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial (H-52305)
Description
Around 1 in 5 people inherit raised levels of a sticky particle called Lp(a) (or lipoprotein(a)) that can lead to cardiovascular disease. So if you’ve had a heart attack or treatment to open a blocked artery, contact our research team to learn about getting your Lp(a) levels tested and the opportunity to take part in important clinical research.
Contact
Phone 1: 713–798–3957
IRB: H-52305
Status:
Active
Created: